About 200 reports

Actinic Keratosis-Market Insights, Epidemiology and Market Forecast-2023

69 pages • By Delve Insight

DelveInsight’s “Actinic Keratosis - Market Insights, Epidemiology and Market Forecast-2023-7MM” report provides an overview of the disease and global market size of the Actinic Keratosis for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for...

4500 4950 3825
May 2017

Phototherapy Equipment - Global Market Outlook (2016-2022)

158 pages • By Stratistics MRC

According to Stratistics MRC, the Global Phototherapy Equipment market is accounted for $474.56 million in 2016 and is expected to reach $660.48 million by 2022 growing at a CAGR of 5.7% during the forecast period 2016 to 2022. The prevailing situations of skin disorders across the globe had created demand for the Phototherapy Equipment market....

3922 4157 2745
Apr 2017

Epidermolysis Bullosa Global Clinical Trials Review, H1, 2017

67 pages • By GlobalData

Epidermolysis Bullosa Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Epidermolysis Bullosa Global Clinical Trials Review, H1, 2017" provides an overview of Epidermolysis Bullosa clinical trials scenario. This report provides top line data relating to the clinical trials on Epidermolysis...

2273 2500 1932
Mar 2017

Topical Drug Delivery Market by Product Type, Transdermal, Route of Administration, & Facility of Use - Global Forecast to 2021

145 pages • By MarketsandMarkets

The global topical drug delivery market is poised to reach USD 125.88 billion by 2021 from USD 92.40 billion in 2016, growing at a CAGR of 6.4% from 2016 to 2021. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes. The topical drug...

5045 5650 4338
Mar 2017

Eczema - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Eczema - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers...

4500 4950 3825
Mar 2017

HIV-associated Lipodystrophy- Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s HIV-associated Lipodystrophy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and...

4500 4950 3825
Mar 2017

Chronic Urticaria Therapeutics - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Chronic Urticaria Therapeutics - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK)...

4500 4950 3825
Mar 2017

Acne And Related Disorders Global Clinical Trials Review, H1, 2017

355 pages • By GlobalData

Acne And Related Disorders Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acne And Related Disorders Global Clinical Trials Review, H1, 2017" provides an overview of Acne And Related Disorders clinical trials scenario. This report provides top line data relating to the clinical...

2273 2500 1932
Feb 2017

Actinic (Solar) Keratosis Global Clinical Trials Review, H1, 2017

178 pages • By GlobalData

Actinic (Solar) Keratosis Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Actinic (Solar) Keratosis Global Clinical Trials Review, H1, 2017" provides an overview of Actinic (Solar) Keratosis clinical trials scenario. This report provides top line data relating to the clinical...

2273 2500 1932
Feb 2017

Global Lifestyle Drugs Market 2017-2021

91 pages • By Infiniti Research Limited

About Lifestyle Drugs Market Lifestyle disease is associated with the way an individual or group of people live. Some of the lifestyle diseases include depression, sexual dysfunction, anti-aging, baldness, and obesity. Technavio’s analysts forecast the global lifestyle drugs market to grow at a CAGR of 2.87% during the...

3398 3500 2922
Feb 2017

Global Acne Therapeutics Market - Growth, Trends and Forecasts (2017 - 2022)

211 pages • By Mordor Intelligence LLP

The global acne therapeutics market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was estimated to be USD XX million in 2015 and is forecasted to reach USD XX million by 2021. Acne is one of the most common skin disorders in the United States, currently, affecting almost 40 - 50 million...

3864 4250 3284
Feb 2017

Global Dermatological therapeutics Market - Growth, Trends and Forecast (2017 - 2022)

211 pages • By Mordor Intelligence LLP

The global Dermatological therapeutics market accounted for a market value of USD XX million in 2015 and is expected to reach USD XX million by 2016. The market is expected to reach USD XX million by 2021, growing at a CAGR of XX% during the forecast period of 2016 to 2021. Dermatological therapeutics are pharmaceuticals that...

3864 4250 3284
Feb 2017

Global Atopic Dermatitis Drugs Market 2017-2021

68 pages • By Infiniti Research Limited

About Atopic Dermatitis Drugs Atopic dermatitis is a common, chronic, relapsing, inflammatory disease that primarily affects young children. Atopy refers to an inherited tendency to produce IgE antibodies, whereas, dermatitis means inflammation of the skin. Atopic dermatitis is associated with asthma, inhalant allergies (hay...

3398 3500 2922
Jan 2017

Atopic dermatitis (AD)- Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Atopic dermatitis (AD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and...

4500 4950 3825
Jan 2017

Atopic dermatitis (AD) - Epidemiology Forecast To 2023

By Delve Insight

DelveInsight “Atopic dermatitis (AD) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Atopic dermatitis (AD) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Atopic dermatitis (AD) prevalent or incident cases segmented...

2500 2750 2125
Jan 2017

Chronic Urticaria Therapeutics - Epidemiology Forecast To 2023

By Delve Insight

DelveInsight “Chronic Urticaria Therapeutics - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Chronic Urticaria Therapeutics in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Chronic Urticaria Therapeutics prevalent...

2500 2750 2125
Jan 2017

Eczema - Epidemiology Forecast To 2023

By Delve Insight

DelveInsight “Eczema - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Eczema in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Eczema prevalent or incident cases segmented by age, sex and subpopulations. The Report...

2500 2750 2125
Jan 2017

Global After Sunburn Care Products Market 2017-2021

77 pages • By Infiniti Research Limited

About After Sunburn Care Products Sun care products protect the skin and hair from harmful UV radiation. Based on their functionality, sun care products can be categorized into three: sun protection, after-sun, and self-tanning products. Technavio’s analysts forecast the global after sunburn care products market to grow at...

3398 3500 2922
Jan 2017

Global Acne Epidemiology and Patient Flow Analysis - 2017

By Fore Pharma

Fore Pharma announced the results of its Acne patients study in a new report ‘Global Acne Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Acne epidemiology, Acne diagnosed patients, and Acne treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence...

1627 1790 1383
Jan 2017

Global Urticaria Epidemiology and Patient Flow Analysis - 2017

By Fore Pharma

Fore Pharma announced the results of its Urticaria patients study in a new report ‘Global Urticaria Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Urticaria epidemiology, Urticaria diagnosed patients, and Urticaria treatment rate for top seven pharmaceutical markets. The study measures key...

1627 1790 1383
Jan 2017

Global Atopic Dermatitis Epidemiology and Patient Flow Analysis - 2017

By Fore Pharma

Fore Pharma announced the results of its Atopic Dermatitis patients study in a new report ‘Global Atopic Dermatitis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Atopic Dermatitis epidemiology, Atopic Dermatitis diagnosed patients, and Atopic Dermatitis treatment rate for top seven pharmaceutical...

1627 1790 1383
Jan 2017

Europe Urticaria Epidemiology and Patient Flow Analysis - 2017

By Fore Pharma

Fore Pharma announced the results of its Urticaria patients study in a new report ‘Europe Urticaria Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Urticaria epidemiology, Urticaria diagnosed patients, and Urticaria treatment rate for EU5 pharmaceutical markets. The study measures key indicators...

1264 1390 1074
Jan 2017

Scleroderma Pipeline Highlights – 2017

By Fore Pharma

The latest report from Fore Pharma, Scleroderma Pipeline Highlights – 2017, provides most up-to-date information on key pipeline products in the global Scleroderma market. It covers emerging therapies for Scleroderma in active clinical development stages including early and late stage clinical trials. The pipeline data presented...

655 720 556
Jan 2017

Rosacea Pipeline Highlights – 2017

By Fore Pharma

The latest report from Fore Pharma, Rosacea Pipeline Highlights – 2017, provides most up-to-date information on key pipeline products in the global Rosacea market. It covers emerging therapies for Rosacea in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this...

655 720 556
Jan 2017

Acne Pipeline Highlights – 2017

By Fore Pharma

The latest report from Fore Pharma, Acne Pipeline Highlights – 2017, provides most up-to-date information on key pipeline products in the global Acne market. It covers emerging therapies for Acne in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps...

655 720 556
Jan 2017

Europe Acne Epidemiology and Patient Flow Analysis - 2017

By Fore Pharma

Fore Pharma announced the results of its Acne patients study in a new report ‘Europe Acne Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Acne epidemiology, Acne diagnosed patients, and Acne treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of...

1264 1390 1074
Jan 2017

Atopic Dermatitis Pipeline Highlights – 2017

By Fore Pharma

The latest report from Fore Pharma, Atopic Dermatitis Pipeline Highlights – 2017, provides most up-to-date information on key pipeline products in the global Atopic Dermatitis market. It covers emerging therapies for Atopic Dermatitis in active clinical development stages including early and late stage clinical trials. The pipeline...

655 720 556
Jan 2017

Europe Atopic Dermatitis Epidemiology and Patient Flow Analysis - 2017

By Fore Pharma

Fore Pharma announced the results of its Atopic Dermatitis patients study in a new report ‘Europe Atopic Dermatitis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Atopic Dermatitis epidemiology, Atopic Dermatitis diagnosed patients, and Atopic Dermatitis treatment rate for EU5 pharmaceutical...

1264 1390 1074
Jan 2017

Actinic Keratosis Pipeline Highlights – 2017

By Fore Pharma

The latest report from Fore Pharma, Actinic Keratosis Pipeline Highlights – 2017, provides most up-to-date information on key pipeline products in the global Actinic Keratosis market. It covers emerging therapies for Actinic Keratosis in active clinical development stages including early and late stage clinical trials. The pipeline...

655 720 556
Jan 2017

Cellulitis Global Clinical Trials Review, H2, 2016

65 pages • By GlobalData

Cellulitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Cellulitis Global Clinical Trials Review, H2, 2016" provides an overview of Cellulitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cellulitis. Report includes an overview of...

2273 2500 1932
Dec 2016